RE:"FORE"! times now...it's important to understand the RUSE... The stock is where it is because TLT haven’t shown that any of their compounds work yet.
The start of Phase II induced whatever the opposite of confidence is. The yet (and probably never) to be revealed reasons for the under-dosing appeared (whatever they were ) scarcely credible. The only thing of substance that we were told was that the Company and no-one else was responsible. This induced a mixture of negativity apathy and outright suspicion among shareholders.
This week’s was great news. Fast track presents the prospect of the present Trial being successfully completed without recourse to further dilution and things more generally are starting to move in the Company’s direction. Preclinical work on x-ray activated Rutherrin in lung and brain cancer and on TLD-1433 at Roswell Park in NSCLC and mesothelioma proceeds unhindered by Covid with a vaccine on the near horizon to enable human trials without delay when they are ready. It is highly likely that they will proceed in humans in at least one major indication in 2021 - not very long from now.
If the compounds are effective - as those of us who have been here for so long are convinced they will be - it will not be possible for Big Pharma to ignore the tech or the Company. The manipulators who have plagued our lives for so long will not be able to keep a lid on the sp.
But the compound will have to be proven to work. That hasn’t happened yet but we should not have long to wait. It will all come down to the Clinic. 2021 should be a very big year for Theralase.